학술논문

Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases.
Document Type
Article
Source
European Journal of Clinical Microbiology & Infectious Diseases. Oct2023, Vol. 42 Issue 10, p1269-1273. 5p.
Subject
*CARBAPENEM-resistant bacteria
*ERTAPENEM
*KLEBSIELLA pneumoniae
*BACTEREMIA
*KLEBSIELLA infections
*URINARY tract infections
*MEROPENEM
Language
ISSN
0934-9723
Abstract
Herein, we aimed to describe the outcomes of patients with blood stream infections due to carbapenem-resistant Klebsiella pneumoniae (CR-Kp) who received ertapenem plus meropenem combination treatment (EMCT). A total of 53 patients with culture proven CR-Kp bacteremia treated with ertapenem + meropenem were included. The patients with secondary bacteremia due to urinary tract infection exhibited a significantly lower 1-month mortality (OMM), particularly in those with microbiological eradication and those with end-of-treatment success. Salvage EMCT resulted in 49% 1-month survival. [ABSTRACT FROM AUTHOR]